Cite
MLA Citation
Saye H Khoo et al.. “Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.” Journal of antimicrobial chemotherapy, vol. 76, 2021, pp. 3286–3295. http://access.bl.uk/ark:/81055/vdc_100146090520.0x000045